Skip to content
★ Sign in to follow
MR

Mark R. Basile

Executive
RX Safes, Inc.BioMETRX
Total declarations
62
Companies
2
▲ Purchases (4 ops.)
€182k
▼ Sales (39 ops.)
€192k

Latest filing published 16 Feb 2016 for RX Safes, Inc..

Insider track record

Disclosed buys
4
Disclosed sells
39
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Mark R. Basile: trading record in brief

Mark R. Basile has filed trades across 2 companies (mainly through SEC (Form 4)), most often in BioMETRX and RX Safes, Inc. We count 62 filings; the first trade dates from 6 January 2006 and the latest from 8 February 2016.

Market trades split into 4 purchases (€182k) and 39 sales (€192k). The net balance comes to €9,759 on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 8 share grants.

In size, the median ticket on the buying side is €26k.

The latest filing, published on 16 February 2016, reports a transaction in RX Safes, Inc. The latest purchase dates back some time: it was published 3,993 days ago, on 3 December 2015. The median gap between a trade and its publication by SEC (Form 4) is 8 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Mark R. Basile

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations62 total
  • ●
    Chief Strategy OfficerExecutivesRX Safes, Inc.
    0SEC
    1,000,000 sharesCommon stock .001 par valueSEC:0001330305-16-000006:0
  • ◆
    DirectorExecutivesRX Safes, Inc.
    0SEC
    1,010 sharesCommon stock .001 par valueSEC:0001330305-16-000005:0
  • ▲
    DirectorExecutivesRX Safes, Inc.
    3,792 USD0SEC
    1,580 shares@ US$2.40Common stock .001 par valueSEC:0001654404-15-000004:0
    Canonical exit: 19 Feb 2016 (T+90)
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    1,400 USD0SEC
    10,000 shares@ US$0.14Common Stock $0.001 par valueSEC:0001144204-08-054336:0
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    1,500 USD0SEC
    10,000 shares@ US$0.15Common Stock $0.001 par valueSEC:0001144204-08-054336:1
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    5,200 USD0SEC
    40,000 shares@ US$0.13Common Stock $0.001 par valueSEC:0001144204-08-054336:2
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    1,200 USD0SEC
    10,000 shares@ US$0.12Common Stock $0.001 par valueSEC:0001144204-08-054336:3
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    1,500 USD0SEC
    10,000 shares@ US$0.15Common Stock $0.001 par valueSEC:0001144204-08-054336:4
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    3,600 USD0SEC
    30,000 shares@ US$0.12Common Stock $0.001 par valueSEC:0001144204-08-054336:5
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    1,300 USD0SEC
    10,000 shares@ US$0.13Common Stock $0.001 par valueSEC:0001144204-08-054336:6
  • ◆
    Chief Executive OfficerExecutivesBioMETRX
    0SEC
    250,000 sharesCommon Stock $0.001 par valueSEC:0001144204-08-054336:7
  • ▲
    Chief Executive OfficerExecutivesBioMETRX
    200,000 USD0SEC
    2,000,000 shares@ US$0.10Common Stock $0.001 par valueSEC:0001144204-08-026347:0
    Canonical exit: 31 Jul 2008 (T+90)
  • ▲
    Chief Executive OfficerExecutivesBioMETRX
    74,400 USD0SEC
    620,000 shares@ US$0.12Common Stock $0.001 par valueSEC:0001144204-08-026347:1
    Canonical exit: 31 Jul 2008 (T+90)
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    8,500 USD0SEC
    12,500 shares@ US$0.68Common Stock $.001 par valueSEC:0001144204-08-006383:0
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    4,950 USD0SEC
    7,500 shares@ US$0.66Common Stock $.001 par valueSEC:0001144204-08-006383:1
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    6,075 USD0SEC
    7,500 shares@ US$0.81Common Stock $.001 par valueSEC:0001144204-08-006383:2
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    5,025 USD0SEC
    7,500 shares@ US$0.67Common Stock $.001 par valueSEC:0001144204-08-006383:3
  • ▼
    Chief Executive OfficerExecutivesBioMETRX
    4,875 USD0SEC
    7,500 shares@ US$0.65Common Stock $.001 par valueSEC:0001144204-08-006383:4
  • ▼
    CHIEF EXECUTIVE OFFICERExecutivesBioMETRX
    3,750 USD0SEC
    5,000 shares@ US$0.75COMMOM STOCK $.001 PER VALUESEC:0001144204-08-003273:0
  • ●
    Chief Executive OfficerExecutivesBioMETRX
    0SEC
    50,000 sharesCommon Stock $.001 par valueSEC:0001144204-07-059093:0
  • ●
    Chief Executive OfficerExecutivesBioMETRX
    0SEC
    114,545 sharesCommon Stock $.001 par valueSEC:0001144204-07-059093:1
  • ▼
    President and CEOExecutivesBioMETRX
    27,200 USD0SEC
    32,000 shares@ US$0.85Common Stock $.001 par valueSEC:0001144204-07-055247:0
  • ●
    President and CEOExecutivesBioMETRX
    0SEC
    28,000 sharesCommon Stock $.001 par valueSEC:0001144204-07-055247:1
  • ●
    President and CEOExecutivesBioMETRX
    0SEC
    50,000 sharesCommon Stock $.001 par valueSEC:0001144204-07-055247:2
  • ●
    President and CEOExecutivesBioMETRX
    0SEC
    25,000 sharesCommon Stock $.001 par valueSEC:0001144204-07-038629:0

25 of 62 declarations